Abstract
Background & Aims: Nonalcoholic steatohepatitis (NASH) is a leading cause of chronic liver disease, characterized by steatosis and hallmark liver neutrophil infiltration. NASH also is associated with adipose tissue inflammation, but the role of adipose tissue inflammation in NASH pathogenesis remains obscure. The aim of this study was to investigate the interplay between neutrophil recruitment in adipose tissue and the progression of NASH. Methods: A mouse model of NASH was obtained by high-fat diet (HFD) feeding plus adenovirus-Cxcl1 overexpression (HFD+AdCxcl1). Genetic deletion of E-selectin (Sele) and treatment with an S100A9 inhibitor (Paquinimod) were investigated using this model. Results: By analyzing transcriptomic data sets of adipose tissue from NASH patients, we found that E-selectin, a key adhesion molecule for neutrophils, is the highest up-regulated gene among neutrophil recruitment-related factors in adipose tissue of NASH patients compared with those in patients with simple steatosis. A marked up-regulation of Sele in adipose tissue also was observed in HFD+AdCxcl1 mice. The HFD+AdCxcl1-induced NASH phenotype was ameliorated in Sele knockout mice and was accompanied by reduced lipolysis and inflammation in adipose tissue, which resulted in decreased serum free fatty acids and proinflammatory adipokines. S100A8/A9, a major proinflammatory protein secreted by neutrophils, was highly increased in adipose tissue of HFD+AdCxcl1 mice. This increase was blunted in the Sele knockout mice. Therapeutically, treatment with the S100A9 inhibitor Paquinimod reduced lipolysis, inflammation, and adipokine production, ameliorating the NASH phenotype in mice. Conclusions: E-selectin plays an important role in inducing neutrophil recruitment in adipose tissue, which subsequently promotes inflammation and lipolysis via the production of S100A8/A9, thereby exacerbating the steatosis-to-NASH progression. Targeting adipose tissue inflammation therefore may represent a potential novel therapy for treatment of NASH.
Original language | English |
---|---|
Pages (from-to) | 151-171 |
Number of pages | 21 |
Journal | CMGH |
Volume | 13 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2022 |
Bibliographical note
Funding Information:Funding Supported by the intramural program of the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health (B.G.). Also supported by fellowship 12H2219N from the Research Foundation Flanders , Belgium (R.M.R.).
Funding Information:
Funding Supported by the intramural program of the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health (B.G.). Also supported by fellowship 12H2219N from the Research Foundation Flanders, Belgium (R.M.R.).
Publisher Copyright:
© 2021
Keywords
- CXCL1
- Neutrophils
- Nonalcoholic Fatty Liver Disease (NAFLD)
- Paquinimod
- Steatohepatitis